ALLO Names Zachary Roberts as President & CEO, $680K Salary, 60% Target Bonus, 476K Stock Option, 135K RSU Award
Allogene Therapeutics, Inc. Common Stock · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) · Now $2.15
-2.7% in 1d after detection
Post-detection moves
1h
+0.1%
1d
-2.7%
3d
—
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS